By Mark Ordonselli
While McGill’s cost-cutting measures will remain in place, staff salary commitments will be honoured and work will soon begin to modernize McGill’s buildings and IT infrastructure, Provost Anthony C. Masi told Senate in his annual budget presentation on April 22.
Two Nobel Prize winners among 16 recipients
From ground-breaking research on the innermost workings of the human body to game-changing discoveries in the outer reaches of space, this year’s recipients of Honorary Degrees from McGill have a universe of experience between them.
By Meaghan Thurston
Two other chairs renewed for McGill researchers
Four new Canada Research Chairs have been awarded to McGill researchers and two others have been renewed, representing a total of $6.6 million in funding over the next five to seven years for research in a range of fields related to health, medicine and engineering.
Deux chaires renouvelées et quatre nouvelles pour des chercheurs de McGill
Quatre nouvelles chaires de recherche du Canada ont été octroyées à des chercheurs de McGill et deux chaires ont été renouvelées, ce qui porte à 6,6 millions de dollars les sommes qui seront versées à l’Université au cours des cinq à sept prochaines années pour la réalisation de travaux dans divers domaines touchant la santé, la médecine et l’ingénierie.
By McGill Reporter Staff
By James Martin
Many of the principal researchers in the McGill University and Génome Québec Innovation Centre came of academic age during the 13-year-long, multi-national Human Genome Project – but it’s the developments since the mapping of the human genome that fill them with wonder.
Directors propose five solutions to improve access to family physicians
The four directors of Quebec universities’ family medicine departments expect Bill 20 will negatively impact patients by reducing the number of new doctors trained and, consequently, the capacity and quality of care.
By Earl Zukerman
Stalled drug trials provide information that needs to be shared
By Katherine Gombay
Lots of potentially useful medical information is getting lost. McGill researchers discovered this when they looked into the lack of reporting of information from “stalled drug” trials in cancer, cardiovascular and neurological diseases.